Key facts
- ALM Ortho’s last known valuation is $13.0M (Jul 2025).
- It has raised $1.0M; the latest was Angel (individual) in Feb 2026.
- Notable investors include Keiretsu Forum, Blu Venture Investors, Beldon Global, Central Texas Angel Network, Charlottesville Angel Network — 7 tracked in total.
- ALM Ortho has filed 1 Form D with the SEC, most recently Jul 2024 ($135K sold to 4 investors).
- Status: Privately Held (backing).
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for ALM Ortho
- ·The full record, as it builds
Funding rounds
No funding rounds for ALM Ortho are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About ALM Ortho
Developer of a medical technology designed to improve and deliver orthopedic implants for the spine. The company's technology leverages additive manufacturing and advanced software tools for patients' complex orthopedic problems, including osseointegration, limb lengthening, total joint arthroplasty revision, and traumatic problems, enabling healthcare institutions to enhance patient outcomes and quality of life.
- Sector
- Healthcare
- HQ
- Scarborough, ME, United States
- Founded
- 2020
- Employees
- 6
- Website
- almortho.com/
- Ownership
- Privately Held (backing)
ALM Ortho doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in ALM Ortho shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on ALM Ortho in its N-PORT filings yet. We sweep new filings monthly.